OMAB(OMAB)
OMAB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $17.65B | $19.66B | $22.29B | $22.81B | $23.37B |
| Low | $17.49B | $18.38B | $20.84B | $21.32B | $21.85B |
| High | $17.82B | $19.82B | $23.57B | $24.11B | $24.70B |
| EBITDA Avg | $11.32B | $12.89B | $14.53B | $16.75B | $18.87B |
| Low | $10.95B | $11.72B | $13.55B | $15.59B | $17.54B |
| High | $11.61B | $13.63B | $15.40B | $17.78B | $20.04B |
| EBIT Avg | $10.25B | $11.62B | $13.05B | $15.09B | $17.05B |
| Low | $9.88B | $10.45B | $12.06B | $13.93B | $15.72B |
| High | $10.53B | $12.36B | $13.92B | $16.11B | $18.22B |
| Net Income Avg | $6.38B | $7.37B | $8.39B | $9.86B | $11.26B |
| Low | $6.12B | $6.52B | $7.68B | $9.02B | $10.31B |
| High | $6.59B | $7.90B | $9.02B | $10.59B | $12.10B |
| EPS Avg | $132.25 | $152.66 | $173.89 | $204.21 | $233.36 |
| Low | $126.71 | $135.14 | $159.18 | $186.93 | $213.61 |
| High | $136.44 | $163.66 | $186.82 | $219.39 | $250.71 |
| Analysts (Rev / EPS) | 5 / 2 | 4 / 3 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.55B | $4.54B | $4.28B | $4.34B | $4.48B | $4.48B | $4.48B | $4.48B |
| Low | $4.33B | $4.45B | $4.27B | $4.33B | $4.47B | $4.47B | $4.47B | $4.47B |
| High | $4.76B | $4.63B | $4.29B | $4.35B | $4.48B | $4.49B | $4.49B | $4.49B |
| EBITDA Avg | $2.93B | $2.87B | $3.03B | $3.42B | $3.70B | $3.42B | $3.40B | $3.95B |
| Low | $2.90B | $2.84B | $3.02B | $3.41B | $3.70B | $3.41B | $3.39B | $3.94B |
| High | $2.94B | $2.89B | $3.03B | $3.42B | $3.71B | $3.43B | $3.41B | $3.95B |
| EBIT Avg | $2.68B | $2.61B | $2.76B | $3.14B | $3.42B | $3.13B | $3.10B | $3.63B |
| Low | $2.66B | $2.59B | $2.75B | $3.13B | $3.41B | $3.12B | $3.09B | $3.63B |
| High | $2.69B | $2.63B | $2.77B | $3.15B | $3.42B | $3.13B | $3.10B | $3.64B |
| Net Income Avg | $1.66B | $1.61B | $1.71B | $1.99B | $2.19B | $1.98B | $1.96B | $2.34B |
| Low | $1.64B | $1.59B | $1.71B | $1.98B | $2.18B | $1.97B | $1.95B | $2.34B |
| High | $1.67B | $1.62B | $1.72B | $1.99B | $2.19B | $1.98B | $1.96B | $2.35B |
| EPS Avg | $34.37 | $33.29 | $35.53 | $41.17 | $45.30 | $40.97 | $40.53 | $48.54 |
| Low | $34.01 | $32.93 | $35.44 | $41.08 | $45.19 | $40.87 | $40.44 | $48.43 |
| High | $34.54 | $33.64 | $35.61 | $41.27 | $45.40 | $41.06 | $40.62 | $48.65 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |